For which medical conditions are central alpha agonists commonly prescribed?

  1. High Blood Pressure, 
  2. Atterton-Deficit/Hyperactivity Disorder (ADHD), 
  3. Spasticity. 
  4. Opioid Disbalance, 
  5. some times Hot Flashes due to Menopause Symptoms. 

Role of Central Alpha Agonists in CNS

  • Alpha 2A: (Brain, Spinal Cord) --- Anesthetic, Sympatholytic Response (Decrease in HR and BP). 
  • Alpha 2B: (Thalamus, Vascular smooth muscle Cells) --- Induction in hypertensive Response (very short term) 
  • Alpha 2C: (Basal Ganglia) --- Modulation in sedative, hypnotic, anxiolytic actions. 

MOA in lowering of BP:




Comments

Post a Comment

Popular posts from this blog

Image
ARACHIDONIC METABOLISM PATHWAY  Introduction Arachidonic Acid pathway describes the synthesis of different Prostanoids (PGs, TXs, Prostacyclin) and Leukotrienes, Cysteinyl Leukotrienes, and Lipoxanes. Steps of AA pathway Step – 01 (Activation of Phospholipase A 2 and release of Arachidonic Acid) Release of AA from phospholipid membrane is carried out by Phospholipase A2 Stimuli initiates the Ca+2 dependent translocation of cytosolic PLA2 to the membrane where it hydrolyses the AA and releases It into the cytosol. Step – 02 (Cyclooxygenase Pathway)  Arachidonic acid is converted to Prostaglandin G2 and Prostaglandin H2 catalyzed by Cyclooxygenase (COX-1 & COX-2) enzyme.  Prostaglandin H2 is then Converted to various Prostanoids by several enzymes- Thromboxane A2 ( Converted by Thromboxane A synthase )  Prostaglandin E2 ( Microsomal Prostaglandin E synthase and cytosolic prostaglandin E Synthase )  Prostaglandin F 2 alpha ( Prostaglandin F synthase ...
Read more
Image
Supraventricular tachycardia (SVT) is an irregularly fast or erratic heartbeat that affects the heart’s upper chambers. The mechanism by which adenosine reduces the incidence of SVTs, particularly atrioventricular nodal reentrant tachycardia (AVNRT) and atrioventricular reentrant tachycardia (AVRT), involves its effects on the AV node.
Read more
Image
Mode of action of Oral hypoglycemic Agents  Sodium-glucose cotransporter 2 (SGLT2) inhibitors, also known as gliflozins , are a class of oral hypoglycemic agents used to lower blood glucose levels in adults with type 2 diabetes. Examples: Dapagliflozin, Empagliflozin etc.   Mode of Action: They work by blocking the function of the SGLT2 protein within the kidneys (PCT, 90% glucose reabsorption). This protein is primarily tasked with the reabsorption of glucose from the glomerular ultrafiltrate .  By inhibiting SGLT2, these drugs prevent the reabsorption of glucose, leading to increased urinary glucose excretion. This mechanism corrects hyperglycemia independently of insulin. As a result, blood glucose levels are reduced.  Note: In addition to their glucose-lowering effect, SGLT2 inhibitors have been found to have benefits on cardiovascular and renal outcomes, independent of their effects on blood glucose. They may also promote weight loss and mo...
Read more